These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy. Durgeau A; Virk Y; Corgnac S; Mami-Chouaib F Front Immunol; 2018; 9():14. PubMed ID: 29403496 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of malignant diseases. Challenges and strategies. Ko EC; Wang X; Ferrone S Int Arch Allergy Immunol; 2003 Dec; 132(4):294-309. PubMed ID: 14707461 [TBL] [Abstract][Full Text] [Related]
11. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies. Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen. Wang X; Luo W; Ferrone S Medicina (B Aires); 2000; 60 Suppl 2():48-50. PubMed ID: 11188931 [TBL] [Abstract][Full Text] [Related]
13. Cellular immunity and immunotherapy of brain tumors. Prins RM; Liau LM Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342 [TBL] [Abstract][Full Text] [Related]
14. MHC class II restricted neoantigen: A promising target in tumor immunotherapy. Sun Z; Chen F; Meng F; Wei J; Liu B Cancer Lett; 2017 Apr; 392():17-25. PubMed ID: 28104443 [TBL] [Abstract][Full Text] [Related]
15. Update on immunotherapy for melanoma. Ribas A J Natl Compr Canc Netw; 2006 Aug; 4(7):687-94. PubMed ID: 16884670 [TBL] [Abstract][Full Text] [Related]
16. Immunologic approaches to ovarian cancer treatment. Sabbatini P; Odunsi K J Clin Oncol; 2007 Jul; 25(20):2884-93. PubMed ID: 17617519 [TBL] [Abstract][Full Text] [Related]
17. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy. Krishnadas DK; Wang Y; Sundaram K; Bai F; Lucas KG Tumour Biol; 2017 Jul; 39(7):1010428317701309. PubMed ID: 28677424 [TBL] [Abstract][Full Text] [Related]
18. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925 [TBL] [Abstract][Full Text] [Related]
19. [Antitumor immunity and cellular cancer therapies]. Catros-Quemener V; Bouet F; Genetet N Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191 [TBL] [Abstract][Full Text] [Related]
20. [Identification of cancer antigens of relevance for specific cancer immunotherapy]. van den Eynde B Bull Mem Acad R Med Belg; 2001; 156(10-12):548-55. PubMed ID: 12371273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]